Point72 Asset Management
RGNX icon

Point72 Asset Management’s Regenxbio RGNX Stock Holding History

Point72 Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-139,791
Closed -$1.17M – 4494
2026
Q1 		$1.17M Buy
139,791
+106,407
+319% +$1.12M ﹤0.01% 2668
2025
Q4 		$481K Buy
+33,384
New +$416K ﹤0.01% 3256
2025
Q1 		– Sell
-200
Closed -$1.55K – 2455
2024
Q4 		$1.55K Buy
+200
New +$1.88K ﹤0.01% 2038
2024
Q2 		– Sell
-1,600
Closed -$33.7K – 2349
2024
Q1 		$33.7K Buy
+1,600
New +$28.5K ﹤0.01% 2084
2023
Q3 		– Sell
-7
Closed -$140 – 2806
2023
Q2 		$140 Buy
+7
New +$135 ﹤0.01% 2051
2022
Q4 		– Sell
-18,500
Closed -$489K – 1748
2022
Q3 		$489K Sell
18,500
-549,000
-97% -$16.3M ﹤0.01% 1174
2022
Q2 		$14M Buy
567,500
+50,233
+10% +$1.25M 0.06% 408
2022
Q1 		$17.2M Buy
+517,267
New +$14.4M 0.07% 366
2021
Q3 		– Sell
-163,608
Closed -$6.36M – 1208
2021
Q2 		$6.36M Sell
163,608
-742,692
-82% -$26.6M 0.03% 557
2021
Q1 		$30.9M Buy
906,300
+773,100
+580% +$33M 0.14% 187
2020
Q4 		$6.04M Buy
+133,200
New +$4.65M 0.03% 551
2020
Q3 		– Sell
-183,756
Closed -$6.77M – 1072
2020
Q2 		$6.77M Buy
+183,756
New +$6.85M 0.04% 423
2017
Q3 		– Sell
-313,586
Closed -$6.19M – 1026
2017
Q2 		$6.19M Buy
313,586
+290,186
+1,240% +$5.62M 0.03% 478
2017
Q1 		$452K Buy
+23,400
New +$451K ﹤0.01% 772

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Point72 Asset Management's RGNX Position: Q2 2026 in Review

Point72 Asset Management sold out of Regenxbio (RGNX) in Q2 2026, closing a stake of 139,791 shares — an estimated $1.17M sold.

Point72 Asset Management first reported a position in RGNX in Q1 2017 and held it in 14 quarters. The position peaked at $30.9M in Q1 2021. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Point72 Asset Management reported no remaining Regenxbio position as of Q2 2026 after selling out during the quarter.
  • Point72 Asset Management sold 139,791 Regenxbio shares in Q2 2026, an estimated $1.17M.
  • Point72 Asset Management first reported a position in Regenxbio in Q1 2017 and held it in 14 quarters.
  • Point72 Asset Management's Regenxbio position peaked at $30.9M in Q1 2021.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.